| Angina pectoris: interventional therapies and treatment of restenosis. | |
| | |
MedLine Citation:
|
PMID: 12818236 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Angina pectoris is a clinical syndrome of symptoms caused by myocardial ischaemia due to oxygen demand exceeding supply. The most common cause is coronary artery stenosis due to progressive atherosclerotic disease. Angina has a prevalence of approximately 5% and increases with age. Despite improvements in treatment there remains a yearly mortality of 2-3%. A major advance in the treatment of symptomatic angina was the introduction of percutaneous transluminal coronary angioplasty (PTCA). This initial enthusiasm was dampened by significant numbers developing symptomatic restenosis from vascular elastic recoil and neointimal hyperplasia (NI). The widespread introduction of stent deployment following the initial angioplasty reduced the rates of elastic recoil but failed to prevent NI and may actually stimulate it. Currently, there is much interest in mechanisms that alter cell proliferation thereby decreasing NI. Techniques include brachytherapy, photodynamic therapy and drug-eluting stents. Provisional data for these new stents, which slowly release medication that inhibits cell turnover, are very good with few occurrences of restenosis. Results from larger randomised trials are awaited. |
| | |
Authors:
|
Sunil V Nair; Jean R McEwan |
Related Documents
:
|
10348536 - A randomized comparison of trapidil (triazolopyrimidine), a platelet-derived growth fac... 17309906 - Prognostic impact of preprocedural c reactive protein levels on 6-month angiographic an... 1998656 - Evaluation of human panelists in assessing coronary atherosclerosis. 9468206 - 'optimal' directional coronary atherectomy: final results of the optimal atherectomy re... 22963346 - Gender disparities in the association between epicardial adipose tissue volume and coro... 2023016 - Predictors of left atrial thrombus in mitral valve disease. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The international journal of biochemistry & cell biology Volume: 35 ISSN: 1357-2725 ISO Abbreviation: Int. J. Biochem. Cell Biol. Publication Date: 2003 Oct |
Date Detail:
|
Created Date: 2003-06-23 Completed Date: 2004-05-11 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9508482 Medline TA: Int J Biochem Cell Biol Country: England |
Other Details:
|
Languages: eng Pagination: 1399-406 Citation Subset: IM |
Affiliation:
|
Centre for Cardiovascular Biology and Medicine, BHF Laboratories, Rayne Building, WC1E 6JJ London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angina Pectoris
/
therapy* Angioplasty, Transluminal, Percutaneous Coronary / adverse effects Brachytherapy Coronary Angiography Coronary Restenosis / therapy* Coronary Thrombosis / etiology, therapy Delayed-Action Preparations / therapeutic use Fibrinolytic Agents / therapeutic use Humans Long-Term Care Models, Biological Platelet Aggregation Inhibitors / therapeutic use Stents / adverse effects |
| Chemical | |
Reg. No./Substance:
|
0/Delayed-Action Preparations; 0/Fibrinolytic Agents; 0/Platelet Aggregation Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Kinetic resolution of 1-chloro-3-(1-naphthyloxy)-2-propanol, an intermediate in the synthesis of bet...
Next Document: Tuberculosis: amplification-based clinical diagnostic techniques.